Download PDF
Thromb Haemost 2017; 117(08): 1571-1581
DOI: 10.1160/TH16-11-0837
Cellular Haemostasis and Platelets
Schattauer GmbH

Microparticles during long-term follow-up after acute myocardial infarction

Association to atherosclerotic burden and risk of cardiovascular events
Christina Christersson
1   Cardiology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden
,
Åsa Thulin
2   Clinical Chemistry, Department of Medical Sciences, Uppsala University, Uppsala, Sweden
,
Agneta Siegbahn
2   Clinical Chemistry, Department of Medical Sciences, Uppsala University, Uppsala, Sweden
› Author Affiliations Financial support: Financial support for this study was received from the Erik, Karin and Gösta Selander Foundation, the Mats Kleberg Foundation, the Fondkistan Foundation and the Swedish Research Council, the Swedish Heart and Lung foundation and the Swedish Foundation for Strategic Research (SSF).
Further Information

Publication History

Received: 07 November 2016

Accepted after minor revision: 05 April 2017

Publication Date:
22 November 2017 (online)

    Permissions and Reprints

Summary

Microparticles (MPs) are formed from platelets (PMPs), endothelial cells (EMPs) and monocytes (MMPs), and in acute myocardial infarction (MI), there is an increase of MPs in the culprit artery. In this study MPs were evaluated in whole blood in 105 patients with MI at five time-points during a two-year follow-up (FU). Patients with non-ST-elevated MI had higher concentrations of CD41+MPs compared to ST-elevated MI patients (p=0.024). The concentrations of PMPs in whole blood increased during the time period (p<0.001), but no significant change over time was found for EMPs and MMPs. CD62P+MP counts were higher in MI patients with diabetes (p=0.020), and patients with hypertension had increased levels of CD14+MPs (p=0.004). The amount of CD62P+TF+MPs increased significantly during FU (p<0.001). Patients with atherosclerosis in three arterial beds, i. e. coronary, carotid and peripheral arteries, had lower concentrations of CD62P+TF+MPs (p=0.035) and CD144+TF+MPs (p=0.004) compared to patients with atherosclerosis in one or two arterial beds. Higher concentrations of CD62P+MPs early after MI were associated with an increased risk of cardiovascular events during FU, hazard ratio 3.32 (95%CI1.20–9.31). Only small variations in PMP, EMP and MMP concentrations were found during long-term FU after MI and their levels seem to reflect the underlying cardiovascular disease rather than the acute MI. PMPs expressing P-selectin might be a promising biomarker for predicting future cardiovascular events, but further studies are needed to confirm these results.

Supplementary Material to this article is available online at www.thrombosis-online.com.

Keywords

P-selectin - tissue factor - atherosclerosis - platelets - endothelial cells

 

  • References

  • 1 Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 2013; 200: 373-383.
    CrossrefPubMedGoogle Scholar
  • 2 Yanez-Mo M, Siljander PR, Andreu Z. et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles 2015; 04: 27066.
    PubMedGoogle Scholar
  • 3 Zhang C, Yang Y. Microparticles are the basic storage units for different proteins in platelet granules. Blood 2012; DOI: doi: 10.1182/blood-2012–04–422907. (Retraction published in Blood 2013; 121 3298
    CrossrefPubMedGoogle Scholar
  • 4 Das S, Halushka MK. Extracellular vesicle microRNA transfer in cardiovascular disease. Cardiovasc Pathol 2015; 24: 199-206.
    CrossrefPubMedGoogle Scholar
  • 5 Habersberger J, Strang F, Scheichl A. et al. Circulating microparticles generate and transport monomeric C-reactive protein in patients with myocardial infarction. Cardiovasc Res 2012; 96: 64-72.
    CrossrefPubMedGoogle Scholar
  • 6 Horn P, Cortese-Krott MM, Amabile N. et al. Circulating microparticles carry a functional endothelial nitric oxide synthase that is decreased in patients with endothelial dysfunction. J Am Heart Assoc 2013; 02: e003764.
    PubMedGoogle Scholar
  • 7 Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med 2008; 359: 938-949.
    CrossrefPubMedGoogle Scholar
  • 8 Blann A, Shantsila E, Shantsila A. Microparticles and arterial disease. Semin Thromb Hemost 2009; 35: 488-496.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Mallat Z, Hugel B, Ohan J. et al. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 1999; 99: 348-353.
    CrossrefPubMedGoogle Scholar
  • 10 Lacroix R, Robert S, Poncelet P. et al. Overcoming limitations of microparticle measurement by flow cytometry. Semin Thromb Hemost 2010; 36: 807-818.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Ayers L, Nieuwland R, Kohler M. et al. Dynamic microvesicle release and clearance within the cardiovascular system: triggers and mechanisms. Clin Sci 2015; 129: 915-931.
    CrossrefPubMedGoogle Scholar
  • 12 Min PK, Kim JY, Chung KH. et al. Local increase in microparticles from the aspirate of culprit coronary arteries in patients with ST-segment elevation myocardial infarction. Atherosclerosis 2013; 227: 323-328.
    CrossrefPubMedGoogle Scholar
  • 13 Porto I, Biasucci LM, De Maria GL. et al. Intracoronary microparticles and microvascular obstruction in patients with ST elevation myocardial infarction undergoing primary percutaneous intervention. Eur Heart J 2012; 33: 2928-2938.
    CrossrefPubMedGoogle Scholar
  • 14 Boulanger CM, Scoazec A, Ebrahimian T. et al. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 2001; 104: 2649-2652.
    CrossrefPubMedGoogle Scholar
  • 15 Bulut D, Tuns H, Mugge A. CD31+/Annexin V+ microparticles in healthy offsprings of patients with coronary artery disease. Eur J Clin Invest 2009; 39: 17-22.
    PubMedGoogle Scholar
  • 16 Rognoni A, Cavallino C, Lupi A. et al. Novel biomarkers in the diagnosis of acute coronary syndromes: the role of circulating miRNAs. Expert Rev Cardiovasc Ther 2014; 12: 1119-1124.
    CrossrefPubMedGoogle Scholar
  • 17 Lacroix R, Judicone C, Mooberry M. et al. Standardisation of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis Haemostasis SSC Collaborative workshop. J Thromb Haemost 2013; 11: 1190-1193.
    CrossrefPubMedGoogle Scholar
  • 18 Shah MD, Bergeron AL, Dong JF. et al. Flow cytometric measurement of micro-particles: pitfalls and protocol modifications. Platelets 2008; 19: 365-372.
    CrossrefPubMedGoogle Scholar
  • 19 van Ierssel SH, Van Craenenbroeck EM, Conraads VM. et al. Flow cytometric detection of endothelial microparticles (EMP): effects of centrifugation and storage alter with the phenotype studied. Thrombosis Res 2010; 125: 332-339.
    CrossrefPubMedGoogle Scholar
  • 20 Christersson C, Johnell M, Siegbahn A. Evaluation of microparticles in whole blood by multicolour flow cytometry assay. Scand J Clin Lab Invest 2013; 73: 229-239.
    CrossrefPubMedGoogle Scholar
  • 21 Jung C, Sorensson P, Saleh N. et al. Circulating endothelial and platelet derived microparticles reflect the size of myocardium at risk in patients with ST-elevation myocardial infarction. Atherosclerosis 2012; 221: 226-231.
    CrossrefPubMedGoogle Scholar
  • 22 Mallat Z, Benamer H, Hugel B. et al. Elevated levels of shed membrane micro-particles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000; 101: 841-843.
    CrossrefPubMedGoogle Scholar
  • 23 Morel O, Pereira B, Averous G. et al. Increased levels of procoagulant tissue factor-bearing microparticles within the occluded coronary artery of patients with ST-segment elevation myocardial infarction: role of endothelial damage and leukocyte activation. Atherosclerosis 2009; 204: 636-641.
    CrossrefPubMedGoogle Scholar
  • 24 Morel O, Hugel B, Jesel L. et al. Sustained elevated amounts of circulating procoagulant membrane microparticles and soluble GPV after acute myocardial infarction in diabetes mellitus. Thromb Haemost 2004; 91: 345-353.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 25 Suades R, Padro T, Vilahur G. et al. Growing thrombi release increased levels of CD235a microparticles and decreased levels of activated platelet-derived micro particles. Validation in ST-elevation myocardial infarction patients. J Thromb Haemost 2015; 13: 1776-1786.
    CrossrefPubMedGoogle Scholar
  • 26 Horn P, Baars T, Kahlert P. et al. Release of Intracoronary Microparticles during Stent Implantation into Stable Atherosclerotic Lesions under Protection with an Aspiration Device. PLoS One 2015; 10: e0124904.
    CrossrefPubMedGoogle Scholar
  • 27 Zeiger F, Stephan S, Hoheisel G. et al. P- Selectin expression, platelet aggregates, and platelet-derived microparticle formation are increased in peripheral arterial disease. Blood Coagul Fibrinolysis 2000; 11: 723-728.
    CrossrefPubMedGoogle Scholar
  • 28 van der Zee PM, Biro E, Ko Y. et al. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myo-cardial infarction. Clin Chem 2006; 52: 657-664.
    CrossrefPubMedGoogle Scholar
  • 29 Christersson C, Johnell M, Siegbahn A. Tissue factor and IL8 production by P-selectin-dependent platelet-monocyte aggregates in whole blood involves phosphorylation of Lyn and is inhibited by IL10. J Thromb Haemost 2008; 06: 986-994.
    CrossrefPubMedGoogle Scholar
  • 30 Evangelista V, Manarini S, Sideri R. et al. Platelet/polymorphonuclear leukocyte interaction: P-selectin triggers protein-tyrosine phosphorylation-dependent CD11b/CD18 adhesion: role of PSGL-1 as a signaling molecule. Blood 1999; 93: 876-885.
    PubMedGoogle Scholar
  • 31 Falati S, Liu Q, Gross P. et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 2003; 197: 1585-1598.
    CrossrefPubMedGoogle Scholar
  • 32 Wang HB, Wang JT, Zhang L. et al. P-selectin primes leukocyte integrin activation during inflammation. Nat Immunol 2007; 08: 882-892.
    CrossrefPubMedGoogle Scholar
  • 33 Morel O, Morel N, Freyssinet JM. et al. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses. Platelets 2008; 19: 9-23.
    CrossrefPubMedGoogle Scholar
  • 34 Nomura S, Inami N, Shouzu A. et al. Correlation and association between plasma platelet-, monocyte- and endothelial cell-derived microparticles in hypertensive patients with type 2 diabetes mellitus. Platelets 2009; 20: 406-414.
    CrossrefPubMedGoogle Scholar
  • 35 Zhang X, McGeoch SC, Johnstone AM. et al. Platelet-derived microparticle count and surface molecule expression differ between subjects with and without type 2 diabetes, independently of obesity status. J Thromb Thrombolysis 2014; 37: 455-463.
    CrossrefPubMedGoogle Scholar
  • 36 Almquist T, Mobarrez F, Jacobson SH. et al. Effects of lipid-lowering treatment on circulating microparticles in patients with diabetes mellitus and chronic kidney disease. Nephrol Dial Transplant 2016; 31: 944-952.
    CrossrefPubMedGoogle Scholar
  • 37 Aberg M, Eriksson O, Siegbahn A. Tissue Factor Noncoagulant Signaling: Mechanisms and Implications for Cell Migration and Apoptosis. Semin Thromb Hemost 2015; 41: 691-699.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 38 Amabile N, Cheng S, Renard JM. et al. Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study. Eur Heart J 2014; 35: 2972-2979.
    CrossrefPubMedGoogle Scholar
  • 39 Koga H, Sugiyama S, Kugiyama K. et al. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 2005; 45: 1622-1630.
    CrossrefPubMedGoogle Scholar
  • 40 Preston RA, Jy W, Jimenez JJ. et al. Effects of severe hypertension on endothelial and platelet microparticles. Hypertension 2003; 41: 211-217.
    CrossrefPubMedGoogle Scholar
  • 41 Montoro-Garcia S, Shantsila E, Tapp LD. et al. Small-size circulating microparticles in acute coronary syndromes: relevance to fibrinolytic status, reparative markers and outcomes. Atherosclerosis 2013; 227: 313-322.
    CrossrefPubMedGoogle Scholar
  • 42 Radecke CE, Warrick AE, Singh GD. et al. Coronary artery endothelial cells and microparticles increase expression of VCAM-1 in myocardial infarction. Thromb Haemost 2015; 113: 605-616.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 43 Cui Y, Zheng L, Jiang M. et al. Circulating microparticles in patients with coronary heart disease and its correlation with interleukin-6 and C-reactive protein. Mol Biol Rep 2013; 40: 6437-6442.
    CrossrefPubMedGoogle Scholar
  • 44 Suades R, Padro T, Crespo J. et al. Circulating microparticle signature in coronary and peripheral blood of ST elevation myocardial infarction patients in relation to pain-to-PCI elapsed time. Int J Cardiol 2016; 202: 378-387.
    CrossrefPubMedGoogle Scholar
  • 45 Hoyer FF, Giesen MK, Nunes Franca C. et al. Monocytic microparticles promote atherogenesis by modulating inflammatory cells in mice. J Cell Mol Med 2012; 16: 2777-2788.
    CrossrefPubMedGoogle Scholar